BioJapan 2022

Lys Therapeutics, a french biotech company developing first-in-class biotherapies against neurological diseases and Grand-Prix i-Lab 2021, is announcing to participating to BioJapan 2022.

Don’t hesitate to reach Philippe Dujardin (CFO) and Dr. Manuel BLANC (CEO) for partnering discussions!

💻 Online Partnering, 12-14 October 2022
📍 Onsite Partnering in Yokohama, 12-14 October 2022